Depends. Good gains there on that industry though. Especially the ones dealing with mrna tech because it's so fucking versatile it can be adapted to any illness (including cancer treatment which is showing some good promise so far) so we'll see flu vaccines using mrna tech and they WILL have better efficacy rates compared to traditional vaccines (traditional vaccines usually have 50-60% efficacy)